Home › Funds › DBA TRADING, LLC › LFCR

DBA TRADING, LLC position in LFCR

LIFECORE BIOMEDICAL INC · Health Care

DBA TRADING, LLC reported holding 75,000 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q2 2026 13F filing — a position valued at US$279K, representing 0.14% of its reported portfolio and ranking #31 among its reported holdings. DBA TRADING, LLC has disclosed LFCR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)75.00K sh
Reported value held$279.00K
Portfolio Weight0.14%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DBA TRADING, LLC's LFCR position evolved

DBA TRADING, LLC first disclosed a stake in LFCR in Q4 2025 at 75,000 shares (US$614K). Across 3 filings, DBA TRADING, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 75,000 shares valued at US$279K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 75.00K $613.50K New
Q1 2026 75.00K $279.00K Hold
Q2 2026 75.00K $279.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LFCR and 13F data

LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 22 other funds we track also report a position in LFCR — the largest reported positions include WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), Greenhaven Road Investment Management, L.P. (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LFCR

All LFCR fund holders →

FAQ

How long has DBA TRADING, LLC held LFCR?

DBA TRADING, LLC has disclosed LFCR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is DBA TRADING, LLC's current position in LFCR?

As of Q2 2026, DBA TRADING, LLC holds 75.00K shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $279.00K, representing 0.14% of its reported portfolio and ranking #31.

Has DBA TRADING, LLC been buying or selling LFCR?

In the latest 13F filing (Q2 2026), DBA TRADING, LLC held unchanged its position in LFCR.

Which other funds hold LFCR?

Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.